M&As this week: Pragmin Prognosis, Forefront Medical Technology

14 September 2017 (Last Updated September 14th, 2017 18:30)

Healthcare and clinical diagnostics company Pragmin Prognosis Inc plans to acquire molecular diagnostics and services company Cynogen Inc (doing business as PersonalizeDx) from genomic diagnostics company Rosetta Genomics Ltd for $2.88m.

Healthcare and clinical diagnostics company Pragmin Prognosis Inc plans to acquire molecular diagnostics and services company Cynogen Inc (doing business as PersonalizeDx) from genomic diagnostics company Rosetta Genomics Ltd for $2.88m.

Forefront Medical Technology Pte Ltd plans to acquire Seychelles-based medical device contract manufacturer Chelle Medical Limited from a group of investors for S$6.8m ($5m).

"The acquisition will enable the Singapore-based company to expand its medical devices products portfolio."

The acquisition will enable the Singapore-based company to expand its medical devices products portfolio.